Processa Pharmaceuticals Inc.

PCSA | NASDAQ

Price Alert Chart Builder DCF Calculator

$1.90

+$0.06 (+3.26%)

Sep 22, 2026, 11:39 AM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Market Data

Market Cap $5.09M

Enterprise Value $4.9M

Beta 0.97

Average Volume 187.19K

Shares Outstanding (Diluted) 2.75M

Shares Change YoY 341.69%

Institutional Ownership N/A

Exchange NASDAQ

ISIN US74275C4033

Price Performance

Price Change 1M -10.2%

Price Change 3M -8.9%

Price Change 6M -20.0%

Price Change YTD -37.2%

Price Change 1Y -62.8%

Price Change 3Y -98.7%

Price Change 5Y -100.0%

1M CAGR (ann.) -28.4%

1Y CAGR (ann.) -64.5%

5Y CAGR (ann.) -77.9%

All-Time CAGR -49.1%

Valuation

PE Ratio -0.33

Forward PE N/A

PEG Ratio -0.00

Forward PEG 0.03

PS Ratio N/A

Forward PS 0.50

PB Ratio -16.05

P/FCF Ratio -0.44

P/Adj. FCF Ratio -0.43

P/OCF Ratio -0.42

EV/Sales N/A

EV/EBIT -0.48

EV/EBITDA -0.48

EV/FCF -0.43

Earnings Yield -304.4%

FCF Yield -225.2%

Adj. FCF Yield -232.8%

Financial Health

Net Cash $196.33K

Total Debt $0

Cash & Short-Term Investments $196.33K

Total Assets $2.07M

Current Ratio 0.87

Quick Ratio 0.87

Debt / Equity Ratio 0.00

Debt / EBITDA -0.00

Debt / FCF -0.00

OCF / Debt N/A

Interest Coverage -6,419.41

Altman Z-Score -87.80

Piotroski F-Score 1

Margins & Profitability

Gross Profit Margin 0.0%

Operating Profit Margin 0.0%

EBITDA Margin 0.0%

Net Profit Margin 0.0%

FCF Margin N/A

Adj. FCF Margin N/A

SBC / Revenue 0.0%

SBC Impact (per share) -3.4%

Returns

Return on Assets -649.3%

Return on Equity -394.2%

Return on Invested Capital 4051.8%

Return on Capital Employed 4051.8%

Return on Tangible Assets -649.3%

Historical Growth (CAGR)

Revenue CAGR 3Y N/A

Revenue CAGR 5Y N/A

Revenue CAGR 10Y -54.5%

EPS CAGR 3Y 94.7%

EPS CAGR 5Y 54.9%

EPS CAGR 10Y 11.7%

FCF CAGR 3Y -10.4%

FCF CAGR 5Y -7.4%

FCF CAGR 10Y -19.4%

Analyst Forecasts

Analyst Rating Buy

Analyst Count 5

EPS Growth Next 3Y 5.1%

Revenue Growth Next 3Y N/A

Earnings Date Oct 28, 2026

EPS Estimate (next Q) -$1

EPS Growth Est (next Q) -42.9%

Revenue Est (next Q) N/A

Revenue Growth Est (next Q) N/A

Fair Value Estimates

Graham Number N/A

Graham Upside N/A

Lynch Fair Value N/A

Lynch Upside N/A

Price Target $225

Price Target Upside 12128.3%

Cash Flow

Operating Cash Flow $-11.97M

Free Cash Flow $-11.47M

Adj. Free Cash Flow $-11.86M

FCF Per Share -$4.17

OCF Per Share -$4.35

OCF/S Ratio 0.0%

Income Statement

Revenue $0

Gross Profit $-301

Operating Income $-10.52M

EBITDA $-10.17M

Net Income $-13.44M

EPS (Diluted) -$5.60

Revenue / Employee N/A

Profit / Employee $-1.12M

Employees 12